סיפרול ER 4.5 מ"ג Израел - Хебрејски - Ministry of Health

סיפרול er 4.5 מ"ג

rafa laboratories ltd - pramipexole dihydrochloride monohydrate 4.5 mg - tablets extended release - pramipexole - treatment of signs and symptoms of idiopathic parkinson’s disease, as monotherapy or in combination with lovodopa.

בטאהיסטין טבע  16 מג Израел - Хебрејски - Ministry of Health

בטאהיסטין טבע 16 מג

abic marketing ltd, israel - betahistine dihydrochloride - טבליה - betahistine dihydrochloride 16 mg - betahistine - betahistine - meniere's syndrom. symptomatic treatment of peripheral vertigo.

אגיסרק 16 Израел - Хебрејски - Ministry of Health

אגיסרק 16

padagis israel pharmaceuticals ltd, israel - betahistine dihydrochloride - טבליה - betahistine dihydrochloride 16 mg - betahistine - betahistine - meniere's syndrom. symptomatic treatment of peripheral vertigo.

זילרג'י Израел - Хебрејски - Ministry of Health

זילרג'י

dexcel ltd, israel - cetirizine dihydrochloride - קפליות - cetirizine dihydrochloride 10 mg - cetirizine - cetirizine - for the treatment of seasonal and perennial allergic rhinitis and of chronic idiopathic urticaria.

טרסבה 150 מג Израел - Хебрејски - Ministry of Health

טרסבה 150 מג

roche pharmaceuticals (israel) ltd - erlotinib as dihydrochloride - טבליות מצופות פילם - erlotinib as dihydrochloride 150 mg - erlotinib - erlotinib - tarceva is indicated for the treatment of patients with locally advanced or metastatic non - small cell lung cancer after failure of at least one prior chemotherapy regimen. tarceva is indicated in combination with gemcitabine for the first-line treatment of patients with locally advanced unresectable or metastatic pancreatic cancer.tarceva® monotherapy is indicated for the maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. tarceva is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with egfr activating mutations.

טרסבה 100 מג Израел - Хебрејски - Ministry of Health

טרסבה 100 מג

roche pharmaceuticals (israel) ltd - erlotinib as dihydrochloride - טבליות מצופות פילם - erlotinib as dihydrochloride 100 mg - erlotinib - erlotinib - tarceva is indicated for the treatment of patients with locally advanced or metastatic non - small cell lung cancer after failure of at least one prior chemotherapy regimen. tarceva is indicated in combination with gemcitabine for the first-line treatment of patients with locally advanced unresectable or metastatic pancreatic cancer.tarceva® monotherapy is indicated for the maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. tarceva is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with egfr activating mutations.

היסטזין Израел - Хебрејски - Ministry of Health

היסטזין

trima israel pharmaceutical products maabarot ltd - cetirizine dihydrochloride - טבליה - cetirizine dihydrochloride 10 mg - cetirizine - cetirizine - antihistaminic drug for the treatment of allergies. for the treatment of seasonal and perennial allergic rhinitis and chronic idiopathic urticaria in children aged 6 years and over and adults.

היסטזין Израел - Хебрејски - Ministry of Health

היסטזין

trima israel pharmaceutical products maabarot ltd - cetirizine dihydrochloride - סירופ - cetirizine dihydrochloride 0.1 %w/v - cetirizine - cetirizine - antihistaminic drug for the treatment of allergies for the treatment of seasonal and perennial allergic rhinitis and chronic idiopathic uriticaria in children aged over 2 years and adults.

קובן Израел - Хебрејски - Ministry of Health

קובן

medison pharma ltd - sapropterin dihydrochloride - טבליות מסיסות - sapropterin dihydrochloride 100 mg - sapropterin - sapropterin - kuvan is indicated for the treatment of hyperphenylalaninaemia (hpa) in adult and paediatric patients of 4 years of age and over with phenylketonuria (pku) who have been shown to be responsive to such treatment.kuvan is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adult and paediatric patients with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

קטג'ל עם לידוקאין Израел - Хебрејски - Ministry of Health

קטג'ל עם לידוקאין

a.lapidot pharmaceuticals ltd, israel - chlorhexidine dihydrochloride; lidocaine hydrochloride - ג'ל - lidocaine hydrochloride 2 %w/w; chlorhexidine dihydrochloride 0.05 %w/w - lidocaine - lidocaine - instillation into the urethra prior to the instillation of catheters or other instruments and manipulations which require the use of a local anesthetic.